Mark Christopher Murray

Insider Reports History

Entity
Individual
Location
100 Matsonford Road, Radnor, PA
Signature
/s/ Blake Feikema, Attorney-in-Fact for Mark Christopher Murray
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Mark Christopher Murray:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Celanese Corp SVP - Acetyls Common Stock 14K $762K $54.45 Mar 7, 2025 Direct
Avantor, Inc. EVP, Biomaterials & AT Common Stock 18.7K $426K $22.83 Jan 13, 2022 Direct
Celanese Corp SVP - Acetyls Nonqualified Stock Option (right to buy) 19K Feb 26, 2025 Direct

Insider Reports Filed by Mark Christopher Murray

Symbol Company Period Transactions Value $ Form Type Date Filed Role
CE Celanese Corp Mar 7, 2025 1 $128K 4 Mar 10, 2025 SVP - Acetyls
CE Celanese Corp Feb 26, 2025 1 $0 4 Feb 28, 2025 SVP - Acetyls
CE Celanese Corp Feb 15, 2025 2 -$25.2K 4 Feb 19, 2025 SVP - Acetyls
CE Celanese Corp Jul 13, 2024 1 -$66.2K 4 Jul 16, 2024 SVP - Acetyls
CE Celanese Corp Mar 8, 2024 1 $93.4K 4 Mar 11, 2024 SVP - Acetyls
CE Celanese Corp Feb 28, 2024 1 $0 4 Mar 1, 2024 SVP - Acetyls
CE Celanese Corp Feb 15, 2024 1 -$18.7K 4 Feb 20, 2024 SVP - Acetyls
CE Celanese Corp Jul 13, 2023 1 -$57.4K 4 Jul 17, 2023 SVP - Acetyls
CE Celanese Corp May 12, 2023 1 $103K 4 May 15, 2023 SVP - Acetyls
CE Celanese Corp Feb 28, 2023 2 $141K 4 Mar 2, 2023 SVP - Acetyls
CE Celanese Corp Feb 15, 2023 1 -$15.1K 4 Feb 17, 2023 SVP - Acetyls
CE Celanese Corp Nov 8, 2022 0 $0 3 Nov 17, 2022 VP - Bus. Strat & Development
AVTR Avantor, Inc. Jan 13, 2022 1 -$34.4K 4 Jan 18, 2022 EVP, Biomaterials & AT